Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01381354
Other study ID # 200911781
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date October 2010
Est. completion date May 2016

Study information

Verified date June 2018
Source University of Iowa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will use a multimodal therapeutic lifestyle intervention consisting of a study diet, stressing more vegetables and fruit, elimination of foods at greatest risk for food allergy, meditation, self massage, progressive exercise and neuromuscular electrical stimulation for rehabilitation of gait and fatigue disability in the setting of secondary and primary progressive multiple sclerosis with gait disability.


Description:

Restoration of function is very rare in individuals with MS who have experienced gradual worsening in the absence of acute MS symptoms (relapses) and partial or complete recovery of those acute symptoms (remissions).

A recent case report of a patient with secondary progressive MS documented a transition from scooter dependence to mild gait disability following the initiation of electrotherapy in the form of neuromuscular electrical stimulation and nutritional interventions aimed increasing the nutrient density and decreasing the risk of food sensitivity and food allergies. Multiple studies of neuromuscular electrical stimulation in athletes, cerebral palsy and stroke patients have demonstrated gains in strength and coordination. Multiple authors have reported that antioxidants, essential amino acids and micronutrient rich diets are neuroprotective. It is likely that the combination of the intensive nutrition and the electrotherapy contributed to the marked gains in improvement. However in the absence of an additional case report the strength of the association remains unknown.

The intent of this study is to replicate the interventions from the case report as closely as possible.

Our primary objective is to measure how many and how completely subjects implement 1) the nutritional interventions, 2) the home exercise program intervention, and 3) the electrotherapy intervention and if the improve improved nutrition and exercise are associated with improved function. To assess improvements in function will measure 1) the change in nutritional status as reported in food frequency surveys, 24 hr dietary recalls, 2) change in neurocognitive testing and behaviors, 3) change in self-reported function and disability scales, 4) change in gait and 5) change in medications doses or classes for MS related symptoms.

Subjects will be followed for three years. After the first year, subjects will not receive intensive support from the study team. The subjects return at months 18, 24 and 36 to assess adherence with study interventions, function and quality of life. Nutrition intake is assessed again at 24 and 36 months.

To assess for safety we will assess safety labs (kidney and liver function tests) and changes in weight, and self reported side effects questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date May 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Secondary or primary progressive multiple sclerosis

- Some level of gait disability

- Tolerance for test electrical therapy session

- Successful completion of two week Run-IN phase completing the daily logs -

- Demonstrating > 80% compliance with dietary and behavioral interventions

Exclusion Criteria:

- Antiplatelet or blood thinning medication

- Cognitive disability or psychiatric disorder making compliance with study interventions difficult

- Implanted electronic medical device

- Change in medication in the prior three months

- Active cancer treatment (skin basal cell or squamous cancer is not an exclusion criteria)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Progressive exercise
Progressive strengthening exercises designed to improve core muscles and muscles of ambulation.
Device:
Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV
Neuromuscular electrical stimulation to train core muscles and ambulation muscles. Device is Empi 300 manufactured by DJO Inc.
Other:
Modified paleolithic diet
Diet based upon a Paleolithic diet and structured to increase the consumption of greens, sulfur rich vegetables, bright colors, seaweed and omega 3 fatty acid rich foods.
Dietary Supplement:
Omega 3 fatty acids
4 grams daily by mouth.
Full Spectrum vitamin
Two capsules daily.
Essential - hydroxytyrosol
Two capsules twice daily.
Maltodextrin fiber supplement
One scoop daily.
Mineral boost (magnesium)
Two capsules daily
Niacinamide
500 mg daily
Methyl B12
Methyl B12 1000 mcg daily
Taurine
one gram daily
creatine
one teaspoon daily
thiamine
100 mg daily
riboflavin
200 mg daily
N acetylcysteine
1 gram daily
alpha lipoic acid
300 mg twice daily
L acetyl carnitine
500 mg twice daily
methyl folate
1000 mcg one pill four times a week
coenzyme Q
100 mg daily
Behavioral:
meditation
meditation 15 minutes daily
self massage
self massage of hands, feet, ears 15 minutes daily
learning
completing puzzles or learning 15 minutes daily
Dietary Supplement:
Coconut oil
If excessive weight loss occurs, the subject will add 1-2 tablespoons of coconut oil daily to smoothies or foods eaten.

Locations

Country Name City State
United States Univeristy of Iowa/ VA Iowa City VA Medical Center Iowa City Iowa

Sponsors (5)

Lead Sponsor Collaborator
University of Iowa Direct MS Canada, DJO Incorporated, Pinnaclife Inc., TZ Press, LLC

Country where clinical trial is conducted

United States, 

References & Publications (2)

Reese D, Shivapour ET, Wahls TL, Dudley-Javoroski SD, Shields R. Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report. Cases J. 2009 Aug 10;2:7601. doi: 10.4076/1757-1626-2-7601. — View Citation

Wahls TL, Reese D, Kaplan D, Darling WG. Rehabilitation with neuromuscular electrical stimulation leads to functional gains in ambulation in patients with secondary progressive and primary progressive multiple sclerosis: a case series report. J Altern Complement Med. 2010 Dec;16(12):1343-9. doi: 10.1089/acm.2010.0080. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Fatigue severity scale Self reported fatigue severity scale, (agreement with 9 questions describing impact of fatigue on daily activities) Baseline, 3 M, 6M, 9M,12 M
Secondary 25 foot walk Average walking speed calculated from 25 foot walk. Distance (feet)walked divided by time in seconds.
Step and stride length, step and stride duration.
baseline, 3M, 6M, 9M, 12M, 18M, 24M 36M
Secondary Short Form 36 Self reported function in multiple domains. baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36 M
Secondary Mood scales Beck depression index, Beck anxiety index Baseline, 3 M, 6M, 9M, 12M
Secondary Cognitive Scales Cognitive stability index or cognitive stability test, subscales of Dkef, Wtar, Wais III. baseline, 3 M, 6M, 9M, 12 M
Secondary Medical Symptoms Questionnaire Detailed review of systems which is scored 0 to 4 for each item. baseline, 1 M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M, 18M, 24M, 36M
Secondary Side effects log Questions about potential side effects from vitamin, supplements and diet, questions about potential side effects from NMES, and questions about potential side effects from exercise. Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M
Secondary MS Function Self reported disability scales (from North American Research committee on Multiple Sclerosis) Baseline, 3 M, 6M, 9M, 12M, 18M, 24M, 36M
Secondary Multiple Sclerosis Spasticity Scale-88 88 Questions about the impact of spasticity on various activities of daily living Baseline, 3M, 6M,9M and 12M, 18M, 24M, 36M
Secondary Daily log Daily reports of foods consumed, exercises and activities completed. Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M
Secondary Vitamin log Log of vitamins supplement bottles date opened, date emptied, pill size, number of pills in bottle. Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M
Secondary Medical examination Medical examination Baseline, 12 M
Secondary Neurological examination Neurological examination Baseline and 12 M
Secondary Exposure history form History of exposures to chemicals. Baseline
Secondary Health questions health questions about chronic disease states Baseline
Secondary Menses and pregnancy risk Questions about menses and potential for pregnancy Baseline, 3M, 6M, 9M, 12M
Secondary Medication audit Medications Baseline, 12 M
Secondary Functional diagnoses Questions about past medical history Baseline
Secondary Manual motor testing Manual motor testing of arms, legs and core muscle groups. Baseline, 3M, 6M, 9M, 12M
Secondary Berg Balance Tests of balance which are progressively more challenging. baseline, 3M, 6M, 9M, 12M
Secondary Modified Ashworth Test of spasticity by physical examination. baseline, 3M, 6M, 9M, 12M
Secondary Circumference Circ. of waist, hips, R and+ L calf and R. and L. thigh. baseline, 3M, 6M, 9M, 12M
Secondary Peak flow Peak expiratory flow rate. baseline, 3M, 6M, 9M, 12M
Secondary Number of falls in prior two months Self reported number of falls and associated factors contributing to fall and severity of fall related injuries. Baseline, 3M, 6M, 9M,12M, 18M, 24M, 36M
Secondary Dietary compliance Assessments, self report, Harvard Food Frequency (baseline, 12 month), 24 hour dietary recalls (6M) Baseline, 6 month and 12 month, 36 month
Secondary Blood pressure blood pressure baseline, 3M, 6M, 9M, 12M
Secondary Waist/ Hip ratio circumference of waist over the circumference of hip baseline, 3M, 6M, 9M, 12M
Secondary MS quality of life- 54 Quality of life questionnaires asking about various aspects of daily life. Baseline and months 3,6,9,12,18,24,and 36
Secondary Blood Biomarkers Blood biomarkers of inflammation, and nutritional status. Baseline, 12 months
Secondary Change in functional and structural brain Magnetic Resonance Imaging (MRI) measures Following sequences:
T1 weighted - Pre Gadolinium T1 weighted -Post Gadolinium T2 weighted FLAIR functional MRI during cognitive task Resting state functional MRI Diffusion Tensor Imaging
Between 1 and 12 month post intervention
Secondary Fatigue severity scale Self reported fatigue severity scale, (agreement with 9 questions describing impact of fatigue on daily activities) 18 M, 24 M, 36 M
Secondary Get up and go test time Total time to get up from chair, walk 10 feet and come back and sit down on the chair.
Step and stride length, step and stride duration and double support time.
Baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36M
Secondary Change in weight and Body mass index (BMI) weight measured in Kg Body mass index (BMI) Baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36M
Secondary Blood safety biomarkers Kidney and liver function tests and complete blood count Baseline, 1M, 3M, 6M, 9M, 12M, 18M, 24M, 36M
Secondary 9 hole peg board test Time to put 9 pegs in holes and take them out. Baseline, 3M, 6M, 9M,12M, 18M, 24M, 36M
Secondary Paced auditory serial addition task (PASAT) Addition of two consecutive numbers during a series of numbers heard by subject. Baseline, 3M, 6M,9M,12M, 18M,24M,36M
Secondary Veteran specific activity questionnaire Questions about the maximum physical activity level. Baseline, 3M, 6M, 9M, 12M, 18M,24M,36M
Secondary Form 38- Daily life Questions about stressful life events. 12M, 18M, 24M, 36M
Secondary Urine toxicology 24 hours urine collection and measurement of heavy metals. Baseline and 12 M
Secondary Stool microbial profile DNA probe for bacteria, parasites and yeast DNA. Baseline and 12M
Secondary Harvard food frequency questionnaire and 24 hour food recalls Questions regarding food intake and frequency of type of food consumed in last one year.
Phone interview asking about food consumed in last 24 hours.
Baseline, 12M, 24M and 36M
Secondary Bio impedance analysis Test to analyze body composition. Baseline, 12M, 24M and 36M
Secondary Exercise and electrical stimulation daily log Record of exercise, use of electrical stimulation on muscles and physical activity. Daily baseline through 12M, 14 day-logs before/after 18M, 24M and 36M
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis